pre-seed
Stage
2019
Founded
1
Investors
About
Cognigenics is a biotechnology company developing RNA-based therapeutics for mood disorders, memory loss, and cognitive impairment through non-invasive, intranasal delivery of siRNA.
Explore Cognigenics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.